We are live on ! Find out more
DM

Deerfield Management Portfolio holdings

AUM $8.48B
1-Year Est. Return 99.04%
This Fund
S&P 500
This Quarter Est. Return
+21.5%
1 Year Est. Return
+99.04%
3 Year Est. Return
+273.78%
5 Year Est. Return
+280.99%
10 Year Est. Return
+2,168.14%
AUM
$5.75B
AUM Growth
+$332M
Cap. Flow
-$28.9M
Cap. Flow %
-0.5%
Top 10 Hldgs %
51.71%
Holding
444
New
223
Increased
65
Reduced
45
Closed
77

Top Buys

Rank Stock Value
1
BNTX icon
BioNTech
BNTX
+$54.6M
2
KYTX icon
Kyverna Therapeutics
KYTX
+$40.8M
3
SGRY icon
Surgery Partners
SGRY
+$33.8M
4
LRMR icon
Larimar Therapeutics
LRMR
+$33.4M
5
ALHC icon
Alignment Healthcare
ALHC
+$30.6M

Top Sells

Rank Stock Value
1
RYZB
RayzeBio, Inc. Common Stock
RYZB
+$62.6M
2
SWTX
SpringWorks Therapeutics
SWTX
+$60.2M
3
BAX icon
Baxter International
BAX
+$55M
4
VKTX icon
Viking Therapeutics
VKTX
+$36.3M
5
NBIX icon
Neurocrine Biosciences
NBIX
+$28.1M

Sector Composition

Rank Sector Weight
1 Healthcare 88.87%
2 Industrials 0.71%
3 Technology 0.31%
4 Consumer Discretionary 0.26%
5 Financials 0.24%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TRGP icon
201
Targa Resources
TRGP
$56.2B
$364K 0.01%
+3,247
New +$306K
MATV icon
202
Mativ Holdings
MATV
$482M
$363K 0.01%
19,384
-4,063
-17% -$60.7K
USNA icon
203
Usana Health Sciences
USNA
$429M
$363K 0.01%
+7,491
New +$367K
LDOS icon
204
Leidos
LDOS
$14.9B
$362K 0.01%
2,758
-1,424
-34% -$170K
RL icon
205
Ralph Lauren
RL
$22.5B
$357K 0.01%
1,903
-816
-30% -$135K
NRC icon
206
NRC Health Common Stock
NRC
$503M
$356K 0.01%
+8,994
New +$356K
CNO icon
207
CNO Financial Group
CNO
$5B
$355K 0.01%
+12,915
New +$349K
DE icon
208
Deere & Co
DE
$173B
$353K 0.01%
+860
New +$330K
PLTR icon
209
Palantir
PLTR
$296B
$353K 0.01%
+15,350
New +$327K
TDC icon
210
Teradata
TDC
$2.75B
$352K 0.01%
+9,102
New +$384K
BGS icon
211
B&G Foods
BGS
$297M
$349K 0.01%
+30,521
New +$320K
COLD icon
212
Americold
COLD
$4.17B
$349K 0.01%
+13,995
New +$382K
LTH icon
213
Life Time Group Holdings
LTH
$10.2B
$349K 0.01%
22,462
+4,154
+23% +$57.7K
AVDX
214
DELISTED
AvidXchange
AVDX
$346K 0.01%
+26,297
New +$316K
PRA
215
DELISTED
ProAssurance
PRA
$345K 0.01%
+26,865
New +$346K
AKRO
216
DELISTED
Akero Therapeutics
AKRO
$345K 0.01%
+13,645
New +$328K
NYT icon
217
New York Times
NYT
$12.2B
$344K 0.01%
+7,964
New +$363K
IMMR icon
218
Immersion
IMMR
$254M
$343K 0.01%
45,826
-13,249
-22% -$94.3K
COLM icon
219
Columbia Sportswear
COLM
$3.3B
$342K 0.01%
+4,216
New +$335K
T icon
220
AT&T
T
$169B
$342K 0.01%
+19,441
New +$332K
WMT icon
221
Walmart Inc
WMT
$900B
$339K 0.01%
+5,637
New +$323K
TTI icon
222
TETRA Technologies
TTI
$1.07B
$338K 0.01%
+76,314
New +$317K
AMCX icon
223
AMC Global Media
AMCX
$451M
$338K 0.01%
+27,839
New +$422K
ARQT icon
224
Arcutis Biotherapeutics
ARQT
$3.55B
$334K 0.01%
+33,714
New +$252K
PEP icon
225
PepsiCo
PEP
$195B
$334K 0.01%
+1,909
New +$321K
7 8
9
10 11

Similar funds

FT
Fiduciary Trust Boston, Massachusetts $8.46B AUM 21.38% 1-Year Est. Return
GRQ
Gardner Russo & Quinn Lancaster, Pennsylvania $8.5B AUM 9.79% 1-Year Est. Return
PCM
Penserra Capital Management Orinda, California $8.52B AUM 37.76% 1-Year Est. Return
VA
Valmark Advisers Akron, Ohio $8.42B AUM 14.36% 1-Year Est. Return
QC
Quadrature Capital London, United Kingdom $8.4B AUM 63.34% 1-Year Est. Return
IC
Icahn Carl Sunny Isles Beach, Florida $8.55B AUM 29.29% 1-Year Est. Return
NW
NewEdge Wealth Pittsburgh, Pennsylvania $8.39B AUM 24.47% 1-Year Est. Return
AAF
Andra AP-fonden Goteborg, Sweden $8.39B AUM 21.19% 1-Year Est. Return

Deerfield Management's Q1 2024 Portfolio in Review

As of Q1 2024, Deerfield Management held 444 positions worth $5.75B, up 6.1% from $5.42B the previous quarter. Its ten largest holdings account for 52% of the portfolio.

Deerfield Management's Q1 2024 filing shows 223 new, 65 increased, 45 reduced and 77 closed positions. Its largest new stake was BioNTech: 569,574 shares worth $52.5M. The largest sale was RayzeBio, Inc. Common Stock, an estimated $62.6M.

By sector, the portfolio is most concentrated in Healthcare at 89% of assets, up from 78% a quarter earlier, followed by Industrials and Technology.

  • Deerfield Management's largest Q1 2024 buy was BioNTech: 569,574 shares worth $52.5M.
  • Deerfield Management added most to Surgery Partners in Q1 2024, an estimated $33.8M increase.
  • Deerfield Management's biggest Q1 2024 reduction was SpringWorks Therapeutics, cutting an estimated $60.2M.
  • Deerfield Management fully exited RayzeBio, Inc. Common Stock in Q1 2024, selling an estimated $62.6M.
  • Deerfield Management's ten largest holdings make up 52% of its $5.75B portfolio in Q1 2024.
  • Deerfield Management opened 223 new positions and closed 77 in Q1 2024.
  • Deerfield Management's portfolio value rose 6.1% quarter-over-quarter to $5.75B.

Based on Deerfield Management's 13F filing for Q1 2024, filed 15 May 2024.